Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting ...

The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.

Senator, Dr. Rasha Kelej, CEO of Merck Foundation, has been featured by a leading lifestyle media organization, Vogue India.

Global pharmaceutical company Merck (NYSE:MRK) in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The ...

Detailed information on the studies selected for ASCO 2025 are as follows: ...

Antengene entered into a global clinical collaboration with MSD (Merck & Co., Inc., Rahway, NJ, USA) on the Phase I/IB STAMINA-01 trial evaluating ATG-037 in combination with MSD's anti-PD-1 therapy, ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany, in partnership with the First Ladies of Africa, proudly ...

Merck Foundation, in collaboration with African First Ladies, revealed the winners of its 2024 Media Recognition Awards. The ...

A surge in measles cases, exceeding 600 infections and resulting in three deaths, has prompted increased vaccinations ...